UK - CGCM UKCGCM. Chairman Professor Ian Sutherland. Dr Jin Xu. 1) Nottingham University

Transcription

1 UK - CGCM Chairman Professor Ian Sutherland Co-Chair Chair Dr Tai-Ping Fan Co-chair Dr Jin Xu 1) Nottingham University UKCGCM Kenneth Muir now moved to Warwick University 2) Oxford University Gerry Bodeker field man Paul Kadetz here - Poster 3) Cambridge University* Tai-Ping Fan Panellist Biological Activities and Mechanism Study II (24/8/10 09:30) 4) Brunel University* Ian Sutherland Panelist International Collaborations (23/8/10 11:30) - co-chair Quality Control Methodology (23/8/10 16:20) 1

2 5) Bradford University* UKCGCM Peter York and Qun Shao who have poster 047 in the session Bioinformatics and Database II (25/8/10 09:00) 6) Royal Botanic Gardens, Kew* Monique Simmonds co-chair Herbal Resources I (Cultivation and Herbal Quality) 7) Wolverhampton University* Kelvin Chan now moved to the University of Sydney and Western Sydney in Australia with Michael Fullen still active at Wolverhampton Kelvin Chan - co-chair Quality Control Methodology (23/8/10 16:20) 8) London School of Pharmacy Michael Heinrich UKCGCM 9) Chinese Medicine Advisory Service, Guys & St Thomas Debbie Shaw 10) The Association of Traditional Chinese Medicines (UK) Dr Shen 11) Centre for Natural Medicines Research, King s s College London Peter Hylands presentation during Quality Control session (23/8/10 16:20) 12) Good Practice in TCMs in the post genomics era (GP-TCM Qihe Xu Principal Investigator of FP7 EU Network 13) Chines Medical Institute and Register (CMIR) Man Fong (Bennie) Mai Chair Education Session (22/8/10 11:30) 14) Thames Valley University Nichola Robinson Panelist Acupuncture (24/8/10 13:30) 2

3 Mission & Goals of UKCGCM To advance the field of Chinese herbal medicine to benefit human kind through joint efforts of the academic institutions, industries and regulatory agencies throughout the UK. To develop platform technologies required for advancing Chinese herbal medicine by joint efforts. To facilitate the interaction and collaboration among different institutes in advancing Chinese herbal medicine by sharing information. To promote a high quality evidence-based research and develop Chinese herbal medicine internationally. To assist industry with the development of new products and their regulatory acceptance Current International Collaborations at Brunel University Host of 8 th CGCM post meeting tour TSB - Scalable Technology for the Extraction of Pharmaceuticals (STEP) - 1.5m Participation in WP1, 2 and 7 of GP-TCM EU Consortium Collaboration with Tsinghua University and Xiang Xue Pharmaceuticals on MCMs Collaboration with Sichuan University West China University 3

4 Good Practice in Traditional Chinese Medicine Research in the Post-genomic Era (GP-TCM) A 3-year 1M European Union Framework Programme 7 (FP7) coordination action project, aiming to inform best practice and harmonise research of the safety and efficacy of Traditional Chinese Medicine (TCM) in the European Union, especially focusing on Chinese herbal medicines (CHM) and acupuncture. It has 10 working groups, 6 focusing on CHMs (QC, extraction methods, toxicology, in vitro, in vivo and clinical pharmacology, as well as regulatory issues), 1 on acupuncture, management and a Final Conference, respectively. GP-TCM currently has 29 beneficiary and 44 non-beneficiary partner institutions across 17 countries, with ~150 PIs. The coordinating institution is King s College London, UK. The heritages of the 3-year consortium will be carried on by a new European society, which will also inherit the CGCM membership. Supporting globalisation of Traditional Chinese Medicines Current IPI research programme in TCM: Established a joint research programme on taste masking for TCM based medicine (Shanghai TCM university) Improvement of bioavailability of TCM based anti-malarials therapy (Shanghai Institute of Materia Medica, Jilin University, Crystec Pharma) Discovery of biomarker associated with disease development and TCM therapies (Tsinghua University) Deformulation and reformulation of TCM cardiovascular products (Xiangxue) Metabomomic/KE approach for explaining clinical outcomes of TCM therapeutics for diabetes (Shanghai Institute of Materia Medica and Zhejiang TCM University) 4

5 Progress of Bradford China Science Bridges Programme Established an open innovation programme in Changzhou: an open innovation workshop organised in December 2009 in Changzhou; 4 UK-China collaborative projects (RMB8m) funded by Changzhou. Further 3 workshops in pipe line in 3 other citites Science Bridges Launch event in Royal Society, London, in February ry 2010 TCM-related Activities of University of Cambridge Aug 2009-Aug First Cambridge TCM Forum as an official activity of Cambridge s s 800th Anniversary Campaign and post-cgcm event after meeting in Notttingham University 2. Visit by a TCM delegation from SW China led by Chengdu U of TCM (arranged by the British Consulate in Chongqing, China) 3. Attended 2009 Shanghai International Conference on Traditional Chinese Medicine and Natural Medicines ( Oct, 2009) 4. Visited Wenshan, Yunnan and Chengdu University of TCM 5. Visit by China Medical University (Taichung( Taichung,, Taiwan) 6. Tai-Ping Fan became Deputy Coordinator of GP-TCM 7. Chaired Natural Products Focused Conference in WorldPharma2010 (Copenhagen, July 2010) 5

6 TCM-related Activities of University of Cambridge Aug 2009-Aug GP-TCM Annual Meeting in Henly-on on-thames: : Regulatory Issues of TCM in consultation with FDA (USA), Natural Health Products Directorate (Canada), Therapeutic Goods Administration (Australia), State Food and Drug Administration (China) and European Medicines Agency 9. Two-week week visit to Shanghai, Beijing and Xi an to discuss and implement collaborations with Shanghai University of TCM, Shangahi Institute of Materia Medica,, IMPLAD of Chinese Academy of Medical Sciences, Beijing University of TCM, Xi an Northwest University 10. Discussion with Chinese Ministry of Science & Technology about China-UK collaboration on TCM 6